|
Alzheimer's Drug Shows Early Promise
Slowed cognitive decline in patients without ApoE4 gene, trial shows
FDA Panel Recommends Enbrel for Pediatric Patients
But experts also express concern about psoriasis drug's possible risks for children; action follows agency warning that drug label needs strengthening
FDA Starts Safety Review of Autoimmune Disorder Drugs
Reports of increased cancer risk among young users of TNF blockers prompts action
Cancer Drug Trials Often Halted Early
Without thorough review, Italian study says the trend poses risks to patients
|
.gif)
